RA
Riyaz Abdul Rehman
About Riyaz Abdul Rehman
Data last updated:
Riyaz Abdul Rehman is a Director at Spry Therapeutics Private Limited (since 2021) and Director at Design Bytes Private Limited (since 2025). The companies operate in Travel and Hospitality and Professional Services. The largest current company by reported revenue is Spry Therapeutics Private Limited at ₹30.15 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Apr 2021 | 2021 | ₹30.15 Cr (FY 2025) | Active | |
| Director | 18 Feb 2025 | 2025 | Active |
Board colleagues of Riyaz Abdul Rehman
| Name | DIN | Company | Designation |
|---|---|---|---|
| Brijraj Bhuptani | 02997706 | Spry Therapeutics Private Limited | Director |
| Roopali Sood | 10955833 | Design Bytes Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Riyaz Abdul Rehman
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Riyaz Abdul Rehman
Riyaz Abdul Rehman currently holds 2 directorships: Spry Therapeutics Private Limited (Director, since 29 Apr 2021, revenue ₹30.15 Cr (FY 2025)); Design Bytes Private Limited (Director, since 18 Feb 2025).
Riyaz Abdul Rehman was first appointed on 29 Apr 2021 as Director at Spry Therapeutics Private Limited. The most recent appointment on record is 18 Feb 2025 at Design Bytes Private Limited.
The current boards of Riyaz Abdul Rehman's companies include Brijraj Bhuptani (Spry Therapeutics Private Limited), Roopali Sood (Design Bytes Private Limited).